Blood tests reveal when lung cancer drugs stop working
NCT ID NCT07475637
Summary
This study looked at whether simple blood tests could help doctors monitor when lung cancer becomes resistant to certain medications. Researchers analyzed medical records and blood samples from 70 advanced lung cancer patients in Tunisia who were taking targeted drugs. They wanted to see if repeated blood testing could detect resistance earlier and help guide treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pathology Department, Charles Nicolle Hospital of Tunis
Tunis, 1007, Tunisia
Conditions
Explore the condition pages connected to this study.